(Q40034454)

16 September 2017

1 reference

title

Rubella: current concepts in epidemiology and teratology (English)

1 reference

16 September 2017

Rubella: Current Concepts in Epidemiology and Teratology (English)

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

2 May 2023

1 reference

A. D. Heggie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5327031

2 May 2023

language of work or name

1 reference

1 May 1966

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:S0031395516318363?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

https://api.elsevier.com/content/article/PII:S0031395516318363?httpAccept=text/plain

2 May 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

Pediatric Clinics of North America

2 May 2023

published in

1 reference

16 September 2017

volume

13

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

251-266

1 reference

VIROLOGIC AND SEROLOGIC STUDIES ON HUMAN PRODUCTS OF CONCEPTION AFTER MATERNAL RUBELLA

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Studies on antibody in congenital rubella infections. I. Physicochemical and immunologic investigations of rubella neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella syndrome and thrombocytopenic purpura in newborn infants. Clinical and virologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Congenital rubella. Clinicopathologic, virologic, and immunologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA EPIDEMIC ON ST. PAUL ISLAND IN THE PRIBILOFS, 1963. I. EPIDEMIOLOGIC, CLINICAL, AND SEROLOGIC FINDINGS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

PREVENTION OF RUBELLA BY GAMMA GLOBULIN DURING AN EPIDEMIC IN BARROW, ALASKA, IN 1964.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA ANTIBODIES IN HUMAN SERUM: DETECTION BY THE INDIRECT FLUORESCENT ANTIBODY TECHNIC.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

BEHAVIOR OF RUBELLA VIRUS IN ADULT POPULATIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

FURTHER SEROLOGICAL STUDIES ON THE RUBELLA SYNDROME.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

The formation of macroglobulin antibodies. II. Studies on neonatal infants and older children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA IN NAVAL RECRUITS; A VIROLOGIC STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

EXPERIMENTAL RUBELLA IN RHESUS MONKEYS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Maternal rubella and the rubella syndrome in infants. Epidemiologic, clinical, and virologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

CONGENITAL RUBELLA INFECTION OF A HUMAN EMBRYO

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Prophylaxis of German measles with immune serum globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Congenital rubella syndrome: study of 22 infants. Myocardial damage and other new clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella: demonstration of neutralizing antibody in gamma globulin and re-evaluation of the rubella problem

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

The formation of macroglobulin antibodies. I. Studies on adult humans

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA VIRUS: INHIBITION IN VITRO BY AMANTADINE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Hemadsorption-negative plaque test: new assay for rubella virus revealing a unique interference

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella infection of human leukocytes. Chromosomal and viral studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Recovery of rubella virus from army recruits.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

PERSISTENCE OF VIRUS IN INFANTS WITH CONGENITAL RUBELLA AND IN NORMAL INFANTS WITH A HISTORY OF MATERNAL RUBELLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

TRANSPLACENTAL RUBELLA INFECTION IN NEWLY BORN INFANTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

VIRUS ISOLATION, INCLUSION BODIES, AND CHROMOSOMES IN A RUBELLA-INFECTED HUMAN EMBRYO

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA COMPLEMENT FIXATION TEST.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

RUBELLA EPIDEMIC ON ST. PAUL ISLAND IN THE PRIBILOFS, 1963. II. CLINICAL AND LABORATORY FINDINGS FOR THE INTENSIVE STUDY POPULATION

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella epidemic, 1964: effect on 6,000 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Fetal death, malformation and prematurity after maternal rubella. Results of a prospective study. 1949-1958

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

FINAL REPORT OF A PROSPECTIVE STUDY OF CHILDREN WHOSE MOTHERS HAD RUBELLA IN EARLY PREGNANCY.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

THE TERATOGENICITY OF MATERNAL RUBELLA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

CYTOGENETIC ANALYSIS OF ABORTUSES FOLLOWING MATERNAL RUBELLA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella (German measles).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Purpura in Congenital and Acquired Rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Pathogenesis of Congenital Rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2931836-3

7 January 2021

Rubella syndrome after inapparent maternal illness

3

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero

2 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

INCIDENCE OF RUBELLA ANTIBODIES IN FEMALE SUBJECTS

2 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

Studies of the natural history and prevention of rubella

2 May 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

Experimental Rubella Virus Infection in Pregnant Monkeys

2 May 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

Osseous manifestations of the congenital rubella syndrome

2 May 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

2 May 2023

CHARGES FOR PATIENTS

61

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)31836-3

2 May 2023

Identifiers

0 references

1 reference